• 1
    Vesprini D, Chung P, Tolan S, et al. Utility of serum tumor markers during surveillance for stage I seminoma. Cancer. 2012;118:5245-5250.
  • 2
    Bruns F, Raub M, Schaefer U, Micke O. No predictive value of beta-hCG in patients with stage I seminoma–results of a long-term follow-up study after adjuvant radiotherapy. Anticancer Res. 2005;25:1543-1546.
  • 3
    Butcher DN, Gregory WM, Gunter PA, Masters JR, Parkinson MC. The biological and clinical significance of HCG-containing cells in seminoma. Br J Cancer. 1985;51:473-478.
  • 4
    Weissbach L, Bussar-Maatz R, Löhrs U, et al. Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group. Eur Urol. 1999;36:601-608.
  • 5
    Cafferty FH, Gabe R, Huddart RA, et al. UK management practices in stage I seminoma and the Medical Research Council Trial of Imaging and Schedule in Seminoma Testis managed with surveillance. Clin Oncol (R Coll Radiol). 2012;24:25-29.